cediranib
4 abstracts
Abstract
Neoplastic and blood-based biomarkers of response in patients with advanced endometrial cancer: Results from NRG GY012.Org: Odette Cancer Centre, Sunnybrook Health Sciences Centre, Duke University Medical Center, NRG Oncology, University of Iowa Hospitals and Clinics,
Abstract
Immune correlates of outcome in patients with leiomyosarcoma (LMS) treated with durvalumab plus olaparib or cediranib: Transcriptome analysis from the DAPPER study.Org: Princess Margaret Cancer Centre, University Health Network, Ontario Institute for Cancer Research, Toronto, ON, Canada, University of Toronto,